Takeda UK and Ireland in the news
Innovating healthcare solutions for patients
Tamtam found 20 recent articles about Takeda UK and Ireland.
- Busting ADHD Myths for Workplace Inclusivity in the U.K.
Takeda UK funded a survey revealing that women and non-binary people with ADHD frequently mask their condition at work to avoid stigma and professional setbacks.
- Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month
Takeda UK funded the Stage4You campaign to provide mental health resources and social media control tools for stage 4 bowel cancer patients.
- A Personal Sentence – Amplifying Neurodiverse Voices in the Criminal Justice System
Takeda UK's campaign urges the government to improve ADHD screening and support within the justice system to reduce recidivism and prison overcrowding.
- Overcoming Challenges in Combination Therapies
Takeda is addressing cost-effectiveness barriers to facilitate patient access to innovative combination therapies in areas like cancer and HIV.
- Combination treatments: Takeda’s Implementation Framework and the broader landscape
Combination treatments improve patient outcomes but face NHS access barriers in the UK due to cost-effectiveness issues; Takeda proposes a framework to enhance access and collaboration.
- Şeyda Atadan Memiş - Takeda - Board Member
Şeyda Atadan Memiş leads Takeda UK & Ireland with extensive pharma experience, focusing on innovation, pricing policy, and strengthening Japanese pharma presence in the UK.
- Deirdre Connaughton appointed as new head of Takeda Bray
Deirdre Connaughton, an 18-year company veteran, has been named the new head of the Takeda Bray manufacturing facility in Ireland.
- NICE relents on Takeda colorectal cancer drug Fruzaqla
NICE has approved Takeda's Fruzaqla for third-line metastatic colorectal cancer treatment in England and Wales after initially rejecting it, while Scotland has not approved it.
- Takeda presents positive results from trial of chronic kidney disease treatment
Positive clinical trial results for mezagitamab show promise in treating chronic kidney disease and signal an upcoming Phase 3 study.
- Takeda receives NICE recommendation for Adcetris combination in Hodgkin lymphoma
NICE recommends Takeda's Adcetris with AVD chemotherapy for untreated late-stage Hodgkin lymphoma, based on improved trial outcomes.
- NICE recommends Takeda’s brentuximab vedotin for HL
NICE endorses brentuximab vedotin plus AVD chemotherapy for advanced CD30+ Hodgkin lymphoma based on clinical trial evidence.
- Takeda announces launch of Framework to help support patient access to life-extending combination treatments
Takeda UK introduced a new Framework addressing cost-effectiveness challenges to enhance patient access to combination treatments within the NHS.
- Innovative Dengue Vaccine Gains Another Authorization
Takeda UK gained MHRA approval for Qdenga®, a dengue vaccine for ages 4+, offering protection against all dengue serotypes and expected in the UK by mid-2023.
- UK MHRA approves Takeda’s dengue vaccine Qdenga
The UK MHRA approved Takeda's Qdenga dengue vaccine for active immunisation in individuals aged four and older, based on robust Phase III trial data.
- NICE recommends Takeda’s Ninlaro triplet regimen
NICE has recommended Takeda's oral drug Ninlaro with lenalidomide and dexamethasone for adults with relapsed or refractory multiple myeloma after two or three prior therapies.
- Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda
Şeyda Atadan Memiş, the newly appointed general manager for Takeda UK and Ireland, shares her career journey, insights on the life sciences industry, and future plans for the company, focusing on patient impact and sustainable growth.
- Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda
Şeyda Atadan Memiş, new general manager of Takeda UK and Ireland, focuses on sustainable growth, innovation, and digital transformation in pharma with a strong patient-centric approach.
- Takeda UK and Ireland appoints new General Manager
Seyda Atadan Memis, experienced leader from Takeda Turkey, appointed General Manager of Takeda UK and Ireland to drive innovation and patient care.
- Takeda UK and Ireland Announces New General Manager
Seyda Atadan Memis becomes General Manager of Takeda UK and Ireland, bringing extensive leadership experience from Takeda Turkey.
- Takeda UK and Ireland Announces New General Manager
Takeda UK and Ireland has appointed Seyda Atadan Memis as its new General Manager, effective August 1, bringing over 20 years of industry experience.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Takeda UK and Ireland?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies